Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
- DOI
- 10.1016/j.ahj.2021.11.009
- Published
- 2022 Mar
- Container
- American heart journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2021.11.009,
title = {Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.},
author = {Akhabue E and Wong M and Mehta R and Isakova T and Wolf M and Yancy C and Gutierrez OM and Carnethon M},
year = {2022},
journal = {American heart journal},
doi = {10.1016/j.ahj.2021.11.009},
url = {https://doi.org/10.1016/j.ahj.2021.11.009}
}RIS
TY - JOUR TI - Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. AU - Akhabue E AU - Wong M AU - Mehta R AU - Isakova T AU - Wolf M AU - Yancy C AU - Gutierrez OM AU - Carnethon M PY - 2022 JO - American heart journal DO - 10.1016/j.ahj.2021.11.009 UR - https://doi.org/10.1016/j.ahj.2021.11.009 ER -
APA
E, A., M, W., R, M., T, I., M, W., C, Y., OM, G., & M, C. (2022). Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.. American heart journal. https://doi.org/10.1016/j.ahj.2021.11.009
Source records
- pubmed · retrieved 2026-11-10T13:42:41.025Z